The mouse model of collagen-induced arthritis
- PMID: 15286392
- DOI: 10.1385/1-59259-805-6:295
The mouse model of collagen-induced arthritis
Abstract
Collagen-induced arthritis (CIA) is an experimental autoimmune disease that can be elicited in susceptible strains of rodents (rat and mouse) and nonhuman primates by immunization with type II collagen (CII), the major constituent protein of articular cartilage. Following immunization, these animals develop an autoimmune polyarthritis that shares several clinical and histological features with rheumatoid arthritis. Susceptibility to CIA in rodents is linked to the class II molecules of the major histocompatibility complex (MHC), and the immune response to CII is characterized by both the stimulation of collagen-specific T cells and the production of high titers of antibody specific for both the immunogen (heterologous CII) and the autoantigen (mouse CII). Histologically, murine CIA is characterized by an intense synovitis that corresponds precisely with the clinical onset of arthritis. Because of the pathological similarities between CIA and rheumatoid arthritis, the CIA model has been the subject of extensive investigation. Here, we describe the specifics for establishing the murine model of CIA, including specific requirements for the handling and preparation of the CII antigen, procedures for immunization, selection of susceptible mouse strains for study, and procedures for the evaluation and quantitation of the autoimmune arthritis.
Similar articles
-
Immunopathogenesis of collagen arthritis.Springer Semin Immunopathol. 2003 Aug;25(1):3-18. doi: 10.1007/s00281-003-0127-1. Springer Semin Immunopathol. 2003. PMID: 12904888 Review.
-
Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.Eur J Immunol. 2002 Dec;32(12):3776-84. doi: 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A. Eur J Immunol. 2002. PMID: 12516572
-
Collagen-induced arthritis.Nat Protoc. 2007;2(5):1269-75. doi: 10.1038/nprot.2007.173. Nat Protoc. 2007. PMID: 17546023
-
Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.Clin Immunol. 2007 Jan;122(1):75-84. doi: 10.1016/j.clim.2006.08.004. Epub 2006 Oct 11. Clin Immunol. 2007. PMID: 17045846
-
Immunogenetics of collagen-induced arthritis.Crit Rev Immunol. 1987;8(1):1-22. Crit Rev Immunol. 1987. PMID: 3121256 Review.
Cited by
-
RTD-1 therapeutically normalizes synovial gene signatures in rat autoimmune arthritis and suppresses proinflammatory mediators in RA synovial fibroblasts.Physiol Genomics. 2019 Dec 1;51(12):657-667. doi: 10.1152/physiolgenomics.00066.2019. Epub 2019 Nov 25. Physiol Genomics. 2019. PMID: 31762409 Free PMC article.
-
A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases.JCI Insight. 2023 Jul 10;8(13):e166137. doi: 10.1172/jci.insight.166137. JCI Insight. 2023. PMID: 37427592 Free PMC article.
-
Synergistic suppression of autoimmune arthritis through concurrent treatment with tolerogenic DC and MSC.Sci Rep. 2017 Feb 23;7:43188. doi: 10.1038/srep43188. Sci Rep. 2017. PMID: 28230210 Free PMC article.
-
IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.J Immunol. 2010 Jun 15;184(12):7144-53. doi: 10.4049/jimmunol.0902739. Epub 2010 May 10. J Immunol. 2010. PMID: 20483737 Free PMC article.
-
Suppression and resolution of autoimmune arthritis by rhesus θ-defensin-1, an immunomodulatory macrocyclic peptide.PLoS One. 2017 Nov 16;12(11):e0187868. doi: 10.1371/journal.pone.0187868. eCollection 2017. PLoS One. 2017. PMID: 29145473 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials